ZA938089B - Novel antimicrobial 5-(N-heterosubstituted amino) quinolones - Google Patents

Novel antimicrobial 5-(N-heterosubstituted amino) quinolones

Info

Publication number
ZA938089B
ZA938089B ZA938089A ZA938089A ZA938089B ZA 938089 B ZA938089 B ZA 938089B ZA 938089 A ZA938089 A ZA 938089A ZA 938089 A ZA938089 A ZA 938089A ZA 938089 B ZA938089 B ZA 938089B
Authority
ZA
South Africa
Prior art keywords
quinolones
novel antimicrobial
heterosubstituted amino
heterosubstituted
amino
Prior art date
Application number
ZA938089A
Other languages
English (en)
Inventor
Thomas Prosser Demuth
Ronald Eugene White
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of ZA938089B publication Critical patent/ZA938089B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Quinoline Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA938089A 1992-10-30 1993-10-29 Novel antimicrobial 5-(N-heterosubstituted amino) quinolones ZA938089B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96896092A 1992-10-30 1992-10-30

Publications (1)

Publication Number Publication Date
ZA938089B true ZA938089B (en) 1994-06-07

Family

ID=25514997

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA938089A ZA938089B (en) 1992-10-30 1993-10-29 Novel antimicrobial 5-(N-heterosubstituted amino) quinolones

Country Status (21)

Country Link
EP (1) EP0666853A1 (pt)
JP (1) JPH08502750A (pt)
KR (1) KR950704301A (pt)
CN (1) CN1064357C (pt)
AU (1) AU687018B2 (pt)
BR (1) BR9307347A (pt)
CA (1) CA2148003A1 (pt)
CZ (1) CZ282581B6 (pt)
EG (1) EG20543A (pt)
FI (1) FI952049A7 (pt)
HU (1) HUT72072A (pt)
IL (1) IL107323A (pt)
MX (1) MX9306814A (pt)
NO (1) NO951640L (pt)
NZ (1) NZ257470A (pt)
PL (1) PL178094B1 (pt)
RU (1) RU2126000C1 (pt)
SG (1) SG59979A1 (pt)
SK (1) SK54795A3 (pt)
WO (1) WO1994010163A1 (pt)
ZA (1) ZA938089B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
CA2196539C (en) * 1994-08-02 2001-05-15 The Procter & Gamble Company Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
WO1996004247A1 (en) * 1994-08-02 1996-02-15 The Procter & Gamble Company Process for making antimicrobial compounds
ATE229950T1 (de) * 1996-02-09 2003-01-15 Toyama Chemical Co Ltd Chinolin carbonsaure-derivate und ihre salze
RU2248199C1 (ru) * 2003-06-02 2005-03-20 Открытое Акционерное Общество "Акционерное Курганское общество медицинских препаратов и изделий "Синтез" (ОАО "Синтез") Глазные капли и способ их получения
RU2265437C2 (ru) * 2003-07-02 2005-12-10 Суханов Александр Владимирович Способ лечения заболеваний желудка и двенадцатиперстной кишки, вызванных helicobacter pylori
RU2245134C1 (ru) * 2003-09-02 2005-01-27 Открытое акционерное общество "Красфарма" Состав офлоксацина для инъекций
WO2005026147A1 (ja) 2003-09-10 2005-03-24 Kyorin Pharmaceutical Co., Ltd. 7−(4−置換−3−シクロプロピルアミノメチル−1−ピロリジニル)キノロンカルボン酸誘導体
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
EP2594272B1 (en) * 2005-05-18 2018-07-11 Horizon Orphan LLC Aerosolized fluoroquinolones and uses thereof
CA2528849C (en) 2005-06-08 2014-01-14 Janssen Pharmaceutica N.V. Quinoline derivatives as antibacterial agents
EA010601B1 (ru) * 2005-06-09 2008-10-30 Янссен Фармацевтика Н.В. Производные хинолина в качестве антибактериальных агентов
CN101020647B (zh) * 2007-02-14 2011-03-30 杭州师范学院 一种β-环丙胺基丙烯酸(酯)的合成方法
JP5363350B2 (ja) * 2007-03-19 2013-12-11 武田薬品工業株式会社 Mapk/erkキナーゼ阻害剤
US7928100B2 (en) * 2007-10-05 2011-04-19 Cylene Pharmaceuticals, Inc. Quinolone analogs and methods related thereto
MX2010012855A (es) * 2008-06-03 2010-12-21 Actelion Pharmaceuticals Ltd Derivados de [4-(1-amino-etil)-ciclohexil]-metil-amina y [6-(1-amino-etil)-tetrahidro-piran-3-il]-metil-amina como antibacterianos.
KR101959873B1 (ko) 2008-10-07 2019-03-19 랩터 파마슈티컬스 인코포레이티드 약동학 개선을 위한 에어로졸 플루오로퀴놀론 제형
CA2739893C (en) 2008-10-07 2016-10-04 Mpex Pharmaceuticals, Inc. Inhalation of levofloxacin for reducing lung inflammation
AR076222A1 (es) * 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
WO2011029059A1 (en) 2009-09-04 2011-03-10 Mpex Pharmaceuticals, Inc. Use of aerosolized levofloxacin for treating cystic fibrosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
JPH0228178A (ja) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
WO1991002526A1 (en) * 1989-08-16 1991-03-07 Pfizer Inc. Azabicyclo quinolone carboxylic acids
ES2147721T3 (es) * 1990-04-18 2000-10-01 Procter & Gamble Pharma Quinolonil lactamas antimicrobianas.
DK0559774T3 (da) * 1990-11-30 2000-01-31 Warner Lambert Co Individuelle stereoisomerer af 7-/3-(1-aminoalkyl)-1-pyrrolidinal/-quinoloner og naphthyridoner som antibakterielle midler

Also Published As

Publication number Publication date
IL107323A0 (en) 1994-01-25
WO1994010163A1 (en) 1994-05-11
HU9501237D0 (en) 1995-06-28
MX9306814A (es) 1994-07-29
AU5409794A (en) 1994-05-24
BR9307347A (pt) 1999-05-25
NO951640L (no) 1995-06-30
PL308671A1 (en) 1995-08-21
RU2126000C1 (ru) 1999-02-10
AU687018B2 (en) 1998-02-19
CN1064357C (zh) 2001-04-11
CN1092773A (zh) 1994-09-28
CA2148003A1 (en) 1994-05-11
IL107323A (en) 2000-06-01
SG59979A1 (en) 1999-02-22
CZ109795A3 (en) 1995-12-13
JPH08502750A (ja) 1996-03-26
EG20543A (en) 1999-07-31
RU95110762A (ru) 1997-01-10
NO951640D0 (no) 1995-04-28
FI952049A0 (fi) 1995-04-28
EP0666853A1 (en) 1995-08-16
PL178094B1 (pl) 2000-02-29
NZ257470A (en) 1997-08-22
HUT72072A (en) 1996-03-28
KR950704301A (ko) 1995-11-17
CZ282581B6 (cs) 1997-08-13
FI952049L (fi) 1995-04-28
FI952049A7 (fi) 1995-04-28
SK54795A3 (en) 1995-12-06

Similar Documents

Publication Publication Date Title
ZA938089B (en) Novel antimicrobial 5-(N-heterosubstituted amino) quinolones
KR100211005B1 (en) Antimicrobial carbapenem quinolones
IL106532A0 (en) Substituted nitrogen-containing heterocycles
EG19861A (en) Novel antimicrobial quinolone thioureas
IL100575A0 (en) Antibacterial agents
HU9403545D0 (en) Herbicidal pyrazole-(thio)-carboxamides
PH29934A (en) Herbicidal 4-benzoyl-isoxazole
GB9117114D0 (en) Herbicidal composition
HU9400384D0 (en) Novel antimicrobial agents
PL297645A1 (en) Novel herbicide
GB9219631D0 (en) Herbicidal compositions
GB9402009D0 (en) Herbicidal composition
PL302321A1 (en) Antimicrobial proteins
PL297750A1 (en) Herbicidal n-cyanopyridazinones
GB9305039D0 (en) Herbicidal composition
ZA936170B (en) Herbicidal compositions
GB9325809D0 (en) Herbicidal composition
AU8228591A (en) Antimicrobial peptides
GB9325810D0 (en) Herbicidal composition
BG97605A (en) Herbicide compound
IL107663A0 (en) Tropone-substituted phenyloxazolidinone antibacterial agents
EP0522372A3 (en) Herbicidal composition
GB9200265D0 (en) Herbicidal composition
GB9317816D0 (en) Antimicrobial proteins
GB9316158D0 (en) Antimicrobial proteins